Latest headlines
Eli Lilly News
The latest Eli Lilly (LLY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these LLY headlines next to the live Eli Lilly Fear and Greed Index.
Latest Eli Lilly Headlines60
Should You Buy Eli Lilly Stock? Here's My Honest Take.
fool.com · Jul 11, 2026
Eli Lilly's $400 Billion Surge Is Reshaping Big Pharma
247wallst.com · Jul 9, 2026
Stocks Look Shaky, But This Sector is Booming (Biotech)
zacks.com · Jul 9, 2026
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
247wallst.com · Jul 9, 2026
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
247wallst.com · Jul 9, 2026
Here's Why Eli Lilly (LLY) is a Strong Growth Stock
zacks.com · Jul 9, 2026
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry
seekingalpha.com · Jul 9, 2026
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
fool.com · Jul 9, 2026
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
prnewswire.com · Jul 9, 2026
Strong LLY News Boosts Active Healthcare ETF GDOC
etftrends.com · Jul 8, 2026
Is It Too Late to Buy Eli Lilly?
fool.com · Jul 8, 2026
The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
marketbeat.com · Jul 8, 2026
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?
zacks.com · Jul 8, 2026
This $1,200 Stock Could Be the Next Massive Stock Split Opportunity
247wallst.com · Jul 8, 2026
Top 50 High-Quality Dividend Growth Stocks For July 2026
seekingalpha.com · Jul 8, 2026
Why Eli Lilly Stock Climbed to a Record High Today
fool.com · Jul 7, 2026
Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They're Dead Wrong
247wallst.com · Jul 7, 2026
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
fool.com · Jul 7, 2026
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
investors.com · Jul 7, 2026
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
247wallst.com · Jul 7, 2026
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
fool.com · Jul 7, 2026
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com · Jul 6, 2026
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
zacks.com · Jul 6, 2026
Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
247wallst.com · Jul 4, 2026
Eli Lilly Price Prediction: The Case for Double-Digit Upside
247wallst.com · Jul 1, 2026
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China
benzinga.com · Jul 1, 2026
New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks
247wallst.com · Jul 1, 2026
Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
Eli Lilly Expands China Cancer Reach
gurufocus.com · Jun 30, 2026
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow
fool.com · Jun 30, 2026
Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder
seekingalpha.com · Jun 30, 2026
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX
fool.com · Jun 30, 2026
China's Innovent Biologics gains commercialization rights for Eli Lilly breast cancer drug
reuters.com · Jun 30, 2026
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
prnewswire.com · Jun 30, 2026
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
zacks.com · Jun 29, 2026
FDA selects Lilly, Regeneron for program to speed up review of new manufacturing facilities, CNBC reports
reuters.com · Jun 29, 2026
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
cnbc.com · Jun 29, 2026
Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs
zacks.com · Jun 29, 2026
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday
zacks.com · Jun 29, 2026
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last?
zacks.com · Jun 29, 2026
3 Monster Stocks to Buy Right Now With Dividend Yields of 5% or More
fool.com · Jun 29, 2026
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
cnbc.com · Jun 28, 2026
Why Eli Lilly Gained 7% On Friday
seekingalpha.com · Jun 28, 2026
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
investors.com · Jun 27, 2026
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
fool.com · Jun 26, 2026
Why Eli Lilly Stock Jumped to a New All-Time High Today
fool.com · Jun 26, 2026
Lilly, J&J and AbbVie Hit New Highs
gurufocus.com · Jun 26, 2026
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
proactiveinvestors.com · Jun 26, 2026
Eli Lilly (LLY) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com · Jun 26, 2026
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
gurufocus.com · Jun 26, 2026
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
prnewswire.com · Jun 26, 2026
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
proactiveinvestors.com · Jun 26, 2026
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
prnewswire.com · Jun 25, 2026
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
prnewswire.com · Jun 24, 2026
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
reuters.com · Jun 23, 2026
Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom
foxbusiness.com · Jun 23, 2026
Biotech's Silent Resurgence (5-Year Base Breakout)
zacks.com · Jun 23, 2026
How Eli Lilly Became a $1 Trillion Company
youtube.com · Jun 23, 2026
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe
reuters.com · Jun 23, 2026
Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout
invezz.com · Jun 23, 2026
Why Is Eli Lilly Up or Down Today?
When Eli Lilly (LLY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a LLY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Eli Lilly is up or down today.
How Eli Lilly News Affects the Price
News does not move the Eli Lilly (LLY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Eli Lilly Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Eli Lilly trading volume. That is the chain to watch: headline, sentiment, volume, then the LLY price.
Trade the Eli Lilly News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Eli Lilly trading volume spike on a big story, check the Eli Lilly price history for context, follow the live LLY price, see the Eli Lilly price prediction, and read the Eli Lilly Fear and Greed Index for mood.
How do you feel about Eli Lilly?
1DFrequently asked questions
Why is Eli Lilly up or down today?
What is the latest Eli Lilly news?
Where does Eli Lilly news come from?
How often is Eli Lilly news updated?
How does Eli Lilly news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and more than 100 individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.